News

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...
this year, doctor houser received the breakthrough prize in life sciences for discovering a treatment that almost eliminates ms. symptoms. IT STARTED OVER 20 YEARS AGO.
The increase in high-efficacy treatment use -- primarily rituximab -- was 89% among Hispanic MS patients, 87% among Black patients, and 83% among White patients after the program was implemented.
Selma Blair has great news to share about her health. As the "Cruel Intentions" star stepped out at The Daily Front Row's 9th annual Fashion Los Angeles Awards on April 24, she told People she's ...
Multiple sclerosis (MS) is a complex disease that often requires a mix of treatments. Some improve symptoms and quality of life. Only one, however, can slow the disease. That treatment is known as ...
Additionally, MindGlide was better than standard tools in quantifying the differences in lesion volume between treatment and placebo groups in the primary progressive MS trial, with 5.31% in FLAIR ...
The answer depends on several factors, noted John Corboy, MD, of the Rocky Mountain MS Center at the University of Colorado in Aurora, at the 2025 Americas Committee for Treatment and Research in ...
Perhaps most concerning is the mortality data – Black Americans under age 55 with MS face higher death rates than their white counterparts, pointing to serious inequities in disease management ...
How multiple sclerosis treatment has changed thanks to annual fundraising Haley Hernandez , Health Reporter Published: March 20, 2025 at 5:49 AM Updated: March 20, 2025 at 8:58 AM ...
Multiple Sclerosis: Causes, Signs and Treatments originally appeared on usnews.com Update 03/10/25: This story was previously published at an earlier date and has been updated with new information ...
Paramagnetic rim lesions help confirm multiple sclerosis diagnoses and may have prognostic value. ... Paramagnetic Rim Lesions May Aid MS Diagnosis and Treatment - Medscape - March 03, 2025.